Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Potentiation of fentanyl-induced respiratory depression by alcohol is not fully reversed by naloxone
Emma V. Frye, Lyndsay E. Hastings, Aniah N. Matthews, Adriana Gregory-Flores, Janaina C.M. Vendruscolo, Lindsay A. Kryszak, Shelley N. Jackson, Aidan J. Hampson, Nora D. Volkow, Leandro F. Vendruscolo, Renata C.N. Marchette, George F. Koob
Emma V. Frye, Lyndsay E. Hastings, Aniah N. Matthews, Adriana Gregory-Flores, Janaina C.M. Vendruscolo, Lindsay A. Kryszak, Shelley N. Jackson, Aidan J. Hampson, Nora D. Volkow, Leandro F. Vendruscolo, Renata C.N. Marchette, George F. Koob
View: Text | PDF
Research Article Neuroscience Public Health

Potentiation of fentanyl-induced respiratory depression by alcohol is not fully reversed by naloxone

  • Text
  • PDF
Abstract

The high frequency of opioid overdose deaths often involves co-use of alcohol, which is reported in approximately 30% of fentanyl fatalities. Both substances depress respiratory function, and their combined effects can be lethal. The present study investigated physiological parameters of respiratory-depressant effects of fentanyl when coadministered with alcohol and their sensitivity to naloxone reversal using whole-body plethysmography in male and female Long-Evans rats. Administration of a high, sedative-like dose of alcohol alone or fentanyl alone resulted in no mortality, but fentanyl plus alcohol led to mortality rates of 42% and 33% in females and males, respectively. The fentanyl+alcohol combination reduced minute ventilation and increased apneic pauses compared with either drug alone. Lower, binge-like alcohol doses when combined with fentanyl also amplified respiratory depression. Pretreatment with naloxone did not fully restore normal respiration. Naloxone administered after fentanyl+alcohol transiently reversed the decrease in minute ventilation but did not reverse apneic pauses. Fentanyl-dependent rats were partially tolerant to fentanyl- and fentanyl+alcohol–induced respiratory depression, but alcohol-dependent rats exhibited sensitization to alcohol- and fentanyl+alcohol–induced apnea. These findings highlight physiological parameters of severe respiratory risks with fentanyl+alcohol co-use, which are inadequately reversed by naloxone, underscoring the need for targeted strategies to manage opioid+alcohol overdoses.

Authors

Emma V. Frye, Lyndsay E. Hastings, Aniah N. Matthews, Adriana Gregory-Flores, Janaina C.M. Vendruscolo, Lindsay A. Kryszak, Shelley N. Jackson, Aidan J. Hampson, Nora D. Volkow, Leandro F. Vendruscolo, Renata C.N. Marchette, George F. Koob

×

Figure 3

Effect of naloxone on respiratory depression induced by fentanyl+alcohol (25 μg/kg + 0.59 g/kg).

Options: View larger image (or click on image) Download as PowerPoint
Effect of naloxone on respiratory depression induced by fentanyl+alcohol...
Rats received an i.v. infusion of a fentanyl+alcohol combination (25 μg/kg and 0.59 g/kg, 2.5 mL/kg), followed by an injection of naloxone (0, 100, 300, and 1,000 μg/kg) 5 min later. (A)Timeline of each test. (B) Naloxone (100 μg/kg) transiently reversed the fentanyl+alcohol–induced decrease in minute ventilation. (C) Naloxone (100 μg/kg) did not change the fentanyl+alcohol–induced increase in apneic pauses. (D) Naloxone (300 and 1,000 μg/kg) reversed fentanyl+alcohol–induced decreases in minute ventilation. (E) Naloxone (300 and 1,000 μg/kg) did not change the fentanyl+alcohol–induced increase in apneic pauses. The data are expressed as the mean ± SEM and were analyzed by 2-way RM-ANOVA followed by Duncan’s post hoc test when appropriate. (F) AUC of the first 15 min after naloxone infusion for minute ventilation. (G) AUC of the first 15 min after naloxone infusion for apneic pauses. (H) AUC of the first 15 min after naloxone infusion for minute ventilation. (I) AUC of the first 15 min after naloxone infusion for apneic pauses. The data are expressed as the mean ± SEM and were analyzed by 2-way RM-ANOVA followed by Šidák’s post hoc test when appropriate. n = 7–10 females, 7 males. (J) Representative raw plethysmography traces.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts